Semaglutide continues to be demonstrated to result in medullary thyroid mobile carcinoma in rodents. Even though its clinical relevance to people is not known, the FDA advises to not administer this drug in These with a personal or household history of medullary thyroid carcinoma. Semaglutide also poses a hazard of pancreatitis and dehydration.para… Read More